The circulating tumor cell market size was valued at $1.1 billion in 2021, and is estimated to reach $5.9 billion by 2031, growing at a CAGR of 18% from 2022 to 2031.
The circulating tumor cell market size was valued at $1.1 billion in 2021, and is estimated to reach $5.9 billion by 2031, growing at a CAGR of 18% from 2022 to 2031.